News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MANCHESTER KEITH S
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/02/2023 |
4
| MANCHESTER KEITH S (Director) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Sold 2,285,783 shares
@ $11.55, valued at
$26.4M
Sold 3,059,368 shares
@ $11.55, valued at
$35.3M
Sold 1,104,599 shares
@ $11.55, valued at
$12.8M
Sold 446,394 shares
@ $11.55, valued at
$5.2M
|
|
| 05/26/2023 |
4
| MANCHESTER KEITH S (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 55,000 options to buy
@ $0 |
|
| 11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2022 |
4
| MANCHESTER KEITH S (Director) has filed a Form 4 on Roivant Sciences Ltd.|
Txns:
| Granted 52,142 shares
@ $0
Granted 71,850 options to buy
@ $3.5, valued at
$251.5k
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2020 |
4
| MANCHESTER KEITH S (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 22,000 options
@ $0 |
|
| 08/20/2019 |
4
| MANCHESTER KEITH S (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 22,000 options
@ $0 |
|
| 06/22/2018 |
4
| MANCHESTER KEITH S (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 22,000 options to buy
@ $6.75, valued at
$148.5k
|
|
| 06/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|